Mergetpa
Mergetpa is a carboxypeptidase inhibitor used to block the conversion of kinins and B2 receptor antagonists to metabolites lacking the C-terminal arginine[1].
Product Specifications
CAS Number
[77102-28-4]
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
Carboxypeptidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/mergetpa.html
Purity
95.20
Solubility
H2O : 15 mg/mL (ultrasonic)
Smiles
O=C(C(CSCCNC(N)=N)CS)O
Molecular Formula
C7H15N3O2S2
Molecular Weight
237.34
Precautions
H302, H315, H319, H335
References & Citations
[1]D Regoli, et al. Conversion of kinins and their antagonists into B1 receptor activators and blockers in isolated vessels. Eur J Pharmacol. 1986 Aug 15;127 (3) :219-24.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rat Monoclonal RAMP2 Antibody (773816) [Janelia Fluor 525]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
